Due to the COVID-19 pandemic, the industry had to rapidly adapt to treating patients remotely, which meant adopting methods for decentralized and hybrid clinical trials, while maintaining data quality and regulatory compliance. There is strong evidence that these new decentralization methods are here to stay. In a recent survey conducted by Informa Intelligence and Oracle Health Sciences, 82 percent of the 251 clinical trial professionals felt that the new approaches they adopted during the pandemic had a positive impact. According to the same survey, 97 percent revealed that their organization plans to continue using at least one of the new methods going forward.
But how do these new methods fit into an existing ecosystem? Unfortunately, many eClinical platforms lack key capabilities, which require complex integrations with third party solutions. This results in a fragmented user experience along with data redundancy and quality issues. Ultimately, this causes delays in gaining access to consolidated data for key stakeholders, which can lead to many problems, including missing critical trial issues that put patients at risk.
In this webinar to learn how a scalable, interconnected platform allows for shared services, enabling an optimized user experience, data interoperability and timely access to all data for critical decision making.
Join this webinar to understand the complexities of decentralized and hybrid clinical trials.
Neil Smith, Director of Clinical Operations (APAC), ObvioHealth Australia Pty Limited
Neil Smith is the Director of Clinical Operations for ObvioHealth based in Melbourne, Australia and is responsible for the oversight of Obvio’s regional APAC studies.
Neil is a Clinical research professional with 25 years of experience in the pharmaceutical industry, having worked in pharmaceutical and CRO companies in Australia, the United Kingdom and South Africa. Neil has worked in a broad range of roles and responsibilities, having worked in leadership teams, and as a Line Manager, Project Manager, Independent Consultant and CRA.
His first monitoring role in the industry was to bring “Telfast” to the world. Later in his career, he worked on more complex clinical trials in HIV in South Africa and conducted predominantly oncology and hematology studies in Australia. He has led and supported several global clinical trials from startup to close out in the general medicine group of large pharma. He has managed all phases of clinical trials.
Jeyaseelan Jeyaraj (Jey), Senior Director, Solutions Consulting, Asia Pacific, Oracle Health Sciences Global Business Unit
Jey is a recognized Digital Health Strategist on addressing the challenges facing the global healthcare & life sciences industry and prospects for improving patient outcomes through better use of data and information. Jey brings over 20 years of broad consulting experience with healthcare providers, public health & pharmaceutical R&D that spans biotech, pharma and CRO.
Jey is the President of the Healthcare Information and Management Systems Society (HIMSS) India chapter. He was the member of the drafting committee for Digital Health Standards, National Accreditation Board for Hospitals & Healthcare Providers (NABH) in India. He has published several papers and articles on digital health technologies. Jey has completed post graduate program in management from University of California (ULCA) Anderson School of Management. Jey is a frequent speaker about healthcare, biopharmaceutical trends and strategy in industry conferences. Jey is the recipient of CXO Health Excellence Award 2021 and recognized as the Top 50 Strategists in Healthcare.
Who Should Attend?
- Director, VP level and Executive Management
- Clinical Operations and Innovations
- Professionals seeking further knowledge on developing their digital strategy for clinical trials
What You Will Learn
- Understand why decentralized and hybrid clinical trials require complex integrations to provide real-world data and patient engagement
- See how a unified platform facilitates streamlined processes by using shared services for study setup and configuration, security and data access through reporting and analytics
- Learn how to implement a scalable, interconnected platform for data interoperability, ensuring timely access to all data for critical decision making
As a leader in Life Sciences cloud technology, Oracle Health Sciences’ Clinical One and Safety One are trusted globally by professionals in both large and emerging companies engaged in clinical research and pharmacovigilance. With over 20 years experience, Oracle Health Sciences is committed to supporting clinical development, delivering innovation to accelerate advancements, and empowering the Life Sciences industry to improve patient outcomes. Oracle Health Sciences. For life.